Emilia Mason is a Postdoctoral Research Scholar at Memorial Sloan Kettering Cancer Center’s Department of Pathology working on numerous clinical investigations of various types of cancers. Her research centers around the development, optimization, and validation of imaging techniques including micro computed tomography (Micro-CT) for multi-modal 3-dimensional (3D) imaging analysis, confocal microscopy to detect fluorescence in situ hybridization (FISH) signals, as well as integrating artificial intelligence to multi-modal imaging. She has prior postdoctoral experience at MSKCC’s Structural Biology Program studying various ligand/receptor signaling systems and the molecular mechanisms of cell-cell interactions as it relates to cancer development, proliferation, and metastatic dissemination. She received her Ph.D. in Chemistry at the University of Missouri from her work that focused on the use of nanotechnology for biomedical applications, specifically targeted drug-delivery. Dr. Mason is dedicated to developing new therapeutic methods for treating various types of cancers.